Anne Longueville SRL
Anne Longueville reported total assets of 29,378 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Anne Longueville shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +151 % Total assets +115 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Anne Longueville's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Anne Longueville's financial analysis
- Solvency71.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Anne Longueville
Anne Longueville's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0834.988.371
- VAT number
- BE0834988371
- Peppol
- Registered · 0208:0834988371 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Mar 2011
- Registered office
- 7190 Écaussinnes
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Anne Longueville (SRL) has been based in Écaussinnes since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 6,021 € and equity of 21,062 €; its revenue is not published. Its solvency stands at 71.7%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Anne Longueville
Companies in the same business, of comparable size and area, outside its group.
- BLAIRVACQ Jean François Retail sale of pharmaceutical products Waremme · balance sheet 29,415 €
- Espace Medical Jumet Retail sale of pharmaceutical products Charleroi · balance sheet 29,613 €
- Deropharma Retail sale of pharmaceutical products Waterloo · balance sheet 29,143 €
- AB Society Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 31,595 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
Frequently asked questions about Anne Longueville
What is the revenue of Anne Longueville?
Anne Longueville files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Anne Longueville?
In Belgium, the VAT number is the company number prefixed with BE: BE0834988371 for Anne Longueville, if the company is VAT-registered. Its company number (CBE) is 0834.988.371.
Where is the registered office of Anne Longueville?
According to the CBE register, the registered office of Anne Longueville is in 7190 Écaussinnes.
What is the equity of Anne Longueville?
At the close of the 2025 financial year, the equity of Anne Longueville amounts to 21,062 €, a solvency of 71.7% of total assets.
Who manages Anne Longueville?
The register lists 1 active mandates at Anne Longueville. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Anne Longueville
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →